Proteon Therapeutics Completes Enrollment in PATENCY-2, Phase 3 Clinical Trial of Investigational Vonapanitase 04/04/2018 iData Research Register to receive a free US Market Report Suite for Dialysis Device and Concentrates report synopsis and brochure Proteon Therapeutics, Inc., a company developing novel, first-in-class therapeutic... Read More
